Pancreatic Cancer Research

ResearcherThe University of Texas MD Anderson Cancer CenterNo recent work listed

Sonal Gupta

Matched on ORCID iD 0000-0003-0594-5102; OpenAlex author ID A5004241959. Sources: OpenAlex.

Their work

Papers
10
Trials
0
Grants
0
Labs led
0
Collaborators
63
Papers, trials and grants by year

2012: 1 paper · 2013: none · 2014: none · 2015: none · 2016: 1 paper · 2017: 1 paper · 2018: 1 paper · 2019: 5 papers · 2020: 1 paper

Papers 10

  1. Interleukin-17-induced neutrophil extracellular traps mediate resistance to checkpoint blockade in pancreatic cancer. Co-author DOI 10.1084/jem.20190354↗
  2. A pipeline for rapidly generating genetically engineered mouse models of pancreatic cancer using in vivo CRISPR-Cas9-mediated somatic recombination. Co-author DOI 10.1038/s41374-018-0171-z↗
  3. Selective EGLN Inhibition Enables Ablative Radiotherapy and Improves Survival in Unresectable Pancreatic Cancer. Co-author DOI 10.1158/0008-5472.can-18-1785↗
  4. Mitochondrial fusion exploits a therapeutic vulnerability of pancreatic cancer. Co-author DOI 10.1172/jci.insight.126915↗
  5. YAP1 oncogene is a context-specific driver for pancreatic ductal adenocarcinoma. Co-author DOI 10.1172/jci.insight.130811↗
  6. Lactate-mediated epigenetic reprogramming regulates formation of human pancreatic cancer-associated fibroblasts. Co-author DOI 10.7554/elife.50663↗
  7. Mitochondrial Fusion Suppresses Pancreatic Cancer Growth via Reduced Oxidative Metabolism Co-author DOI 10.2139/ssrn.3188491↗
  8. Altered hydroxymethylation is seen at regulatory regions in pancreatic cancer and regulates oncogenic pathways. Co-author DOI 10.1101/gr.222794.117↗
  9. In Vivo Functional Platform Targeting Patient-Derived Xenografts Identifies WDR5-Myc Association as a Critical Determinant of Pancreatic Cancer. Co-author DOI 10.1016/j.celrep.2016.05.063↗
  10. Molecular determinants of retinoic acid sensitivity in pancreatic cancer. Co-author DOI 10.1158/1078-0432.ccr-11-2165↗

Closest collaborators

The 25 strongest of 63 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Anirban Maitra · 10 shared papers, 2012–2020 · strength 0.65
  2. Ya’an Kang · 4 shared papers, 2016–2019 · strength 0.25
  3. Jason B. Fleming · 4 shared papers, 2016–2019 · strength 0.25
  4. Tara N. Fujimoto · 3 shared papers, 2018–2019 · strength 0.22
  5. Meifang Yu · 3 shared papers, 2018–2019 · strength 0.22
  6. Cullen M. Taniguchi · 3 shared papers, 2018–2019 · strength 0.22
  7. Daniel Lin · 3 shared papers, 2018–2019 · strength 0.22
  8. Eugene Jon Koay · 3 shared papers, 2018–2019 · strength 0.22
  9. Huamin Wang · 3 shared papers, 2016–2020 · strength 0.19
  10. Haoqiang Ying · 2 shared papers, 2019 · strength 0.14
  11. Tushar Damodar Bhagat · 2 shared papers, 2017–2019 · strength 0.12
  12. Sanchari Bhattacharyya · 2 shared papers, 2017–2019 · strength 0.12
  13. Amit K. Verma · 2 shared papers, 2017–2019 · strength 0.12
  14. Timothy Paul Heffernan · 2 shared papers, 2016–2019 · strength 0.11
  15. Wantong Yao · 2 shared papers, 2016–2019 · strength 0.11
  16. Giulio Francesco Draetta · 2 shared papers, 2016–2019 · strength 0.11
  17. Takashi Okumura · 1 shared paper, 2019 · strength 0.09
  18. Noboru Ideno · 1 shared paper, 2019 · strength 0.09
  19. Bidyut Ghosh · 1 shared paper, 2019 · strength 0.09
  20. Michael Goggins · 2 shared papers, 2012–2019 · strength 0.09
  21. Sulagna Banerjee · 1 shared paper, 2020 · strength 0.08
  22. Yu Zhang · 1 shared paper, 2020 · strength 0.08
  23. Erick Marcelo Riquelme Sanchez · 1 shared paper, 2020 · strength 0.08
  24. Prasanta Dutta · 1 shared paper, 2020 · strength 0.08
  25. Vidhi Chandra · 1 shared paper, 2020 · strength 0.08

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.